← Back to Search

Pharmacist Management for Lower Urinary Tract Symptoms

N/A

Waitlist Available

Led By Cheryl A Sadowski, Pharm.D.

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥60 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 8 weeks post-intervention

Awards & highlights

Study Summary

This trial will study how much benefit there is if pharmacists provide more assistance to seniors with urinary incontinence. Over a period of months, half of the people who talk to the pharmacist about their incontinence will be given general information about health and aging. The other half of the people will have a longer assessment and complete a questionnaire with the pharmacist. The pharmacist will then call and have a follow-up visit to see how the incontinence symptoms have improved. We will compare both groups to see whose symptoms were improved.

Who is the study for?

This trial is for individuals aged 60 or older who experience lower urinary tract symptoms (LUTS) and can read and communicate in English. Participants must be willing to consent to the study procedures and available for follow-up visits.Check my eligibility

What is being tested?

The trial is testing two approaches by community pharmacists: one group will receive general healthy aging leaflets, while the other will undergo a detailed assessment, complete a questionnaire, and have follow-up interactions with the pharmacist about managing LUTS.See study design

What are the potential side effects?

Since this trial involves non-invasive interventions like reviews and provision of information rather than medications or medical procedures, there are no direct side effects associated with these activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 60 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 8 weeks post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 8 weeks post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 8 weeks post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Patient Perception of Bladder Condition (PPBC)

Secondary outcome measures

Change in Bladder Self-Assessment Questionnaire (B-SAQ)

Change in International Consultation on Incontinence Module Questionnaire Short Form (ICI-Q-SF)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Pharmacist InterventionExperimental Treatment1 Intervention

Pharmacist assessment of LUTS, with recommendations and education regarding lifestyle, behaviour, and/or medications related to bladder health. Follow-up at 3 and 6 weeks.

Group II: ControlActive Control1 Intervention

Pharmacist questions regarding presence of LUTS, with provision of healthy aging literature. Follow-up at 6 weeks.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

384,678 Total Patients Enrolled

PfizerIndustry Sponsor

4,567 Previous Clinical Trials

10,907,950 Total Patients Enrolled

3 Trials studying Lower Urinary Tract Symptoms

682 Patients Enrolled for Lower Urinary Tract Symptoms

Cheryl A Sadowski, Pharm.D.Principal InvestigatorUniversity of Alberta

Media Library

Pharmacist review of LUTS Clinical Trial Eligibility Overview. Trial Name: NCT04331340 — N/A

Lower Urinary Tract Symptoms Research Study Groups: Pharmacist Intervention, Control

Lower Urinary Tract Symptoms Clinical Trial 2023: Pharmacist review of LUTS Highlights & Side Effects. Trial Name: NCT04331340 — N/A

Pharmacist review of LUTS 2023 Treatment Timeline for Medical Study. Trial Name: NCT04331340 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left for prospective participants in this clinical trial?

"Affirmative. Clinicaltrials.gov displays that this investigation is currently recruiting participants, having first been posted on April 26th 2021 and updated most recently on June 30th 2022. The research initiative requires 100 individuals to be recruited from a single medical centre."

Answered by AI

To what extent is enrollment available for this clinical experiment?

"Accurate. Clinicaltrials.gov indicates that this clinical experiment, initially posted on April 26th 2021, is actively recruiting individuals to participate in the study. 100 participants are anticipated at a single site across the duration of the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Management of LUTS by Community Pharmacists

2021. "Management of LUTS by Community Pharmacists". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04331340.